CHUGAI PHARMACEUTICAL CO.,LTD. [4519.T]
TOKYO, Apr 24 (Pulse News Wire) – Chugai Pharmaceutical CO.,LTD. (4519.T) detailed its share buyback plan associated with the introduction of a trust-based equity compensation system during today’s board meeting.
The company previously announced plans for this system on January 29, which was approved at the 115th Ordinary General Meeting of Shareholders held on March 26. Under the new scheme, Chugai will acquire shares worth up to [TICKER_0] through open-market purchases between April 27, 2026, and May 31, 2026. The shares will be used for incentive purposes targeting directors and executives.
Additionally, the company will also purchase shares worth up to [TICKER_1] for employee incentives, with acquisitions set to take place from May 1, 2026, until May 31, 2026. Both trusts will operate under agreements with Mitsubishi UFJ Trust and Banking Corporation and Sumitomo Mitsui Trust Bank, with independent trustees managing the funds. The trusts aim to enhance motivation among key personnel without exercising voting rights.
The duration of both programs spans from April 27, 2026, to the end of May 2030.
🟢 Confidence: High AI-translated content.